Justine Kahn, MD

Justine Kahn, MD is a renowned Pediatric Oncologist located at 161 Fort Washington Avenue in New York, New York, United States. Dr. Kahn specializes in survival outcomes, cancer care delivery, and health equity for children and adolescent/young adults with Hodgkin lymphoma, non-Hodgkin lymphoma, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL). She received her MD from the Icahn School of Medicine at Mount Sinai and completed her Pediatric Residency at Mount Sinai Kravis Children's Hospital. Dr. Kahn also completed her Clinical Fellowship in Pediatric Hematology/Oncology at Columbia University Medical Center.

Dr. Kahn is dedicated to patient care, clinical trials research, and health outcomes research. She is actively involved in research studies through the Dana-Farber Cancer Institute ALL Consortium, Children's Oncology Group, and Columbia University. Her focus on underserved populations stems from the belief that poor access-to-care, low health literacy, and financial stress can impact survival rates in children and AYAs with cancer.

Dr. Kahn is supported by the Lymphoma Research Foundation and has received a Career Development Award for her work on survival disparities in Hodgkin lymphoma patients. She serves as the CUMC site Principal Investigator for the DFCI ALL Consortium. Dr. Kahn's commitment to health equity and research makes her a valuable asset in the field of pediatric oncology.